Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)

Pathway network for the Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) SuperPath

Sources:
  • Reactome

Pathways in the Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) SuperPath

#NameSourceGenes
1Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)Reactome
2Resolution of D-Loop StructuresReactome
3Resolution of D-loop Structures through Holliday Junction IntermediatesReactome
4Defective homologous recombination repair (HRR) due to PALB2 loss of functionReactome
5Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding functionReactome
6Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding functionReactome
7Defective homologous recombination repair (HRR) due to BRCA1 loss of functionReactome
8Impaired BRCA2 binding to PALB2Reactome

Gene overlap in member pathways for Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Breast cancerEnrichmentATM, BARD1, BLM, BRCA1, BRCA2, BRIP1, MRE11, NBN, PALB2, RAD50, RAD51, RAD51C, RAD51D, XRCC2, XRCC316.00
2Ovarian cancerEnrichmentATM, BARD1, BLM, BRCA1, BRCA2, BRIP1, MRE11, NBN, PALB2, RAD50, RAD51C, RAD51D, WRN16.00
3Pancreatic cancerEnrichmentATM, BRCA1, BRCA2, BRIP1, NBN, PALB2, RBBP816.00
4Hereditary breast ovarian cancer syndromeEnrichmentATM, BARD1, BLM, BRCA1, BRCA2, BRIP1, MRE11, NBN, PALB2, RAD50, RAD51, RAD51B, RAD51C, RAD51D, XRCC216.00
5Fanconi anemia, complementation group aEnrichmentBRCA1, BRCA2, BRIP1, PALB2, RAD51, RAD51C, SLX4, XRCC216.00
6Gastric cancerEnrichmentATM, BARD1, BRCA1, BRCA2, BRIP1, NBN, PALB2, RAD51C, RAD51D16.00
7Hereditary breast carcinomaEnrichmentATM, BARD1, BLM, BRCA1, BRCA2, BRIP1, NBN, PALB2, RAD50, RAD51, RAD51D16.00
8Colorectal cancerEnrichmentATM, BLM, BRCA1, BRCA2, BRIP1, PALB2, RAD51D, RMI116.00
9Breast-ovarian cancer, familial 1EnrichmentATM, BRCA1, BRCA2, BRIP1, NBN, PALB2, RAD51C, RAD51D11.52
10Uterine corpus cancerEnrichmentATM, BRCA1, BRCA2, BRIP1, PALB2, RAD51C11.39
11Inherited cancer-predisposing syndromeEnrichmentATM, BARD1, BLM, BRCA1, BRCA2, BRIP1, MRE11, NBN, PALB2, RAD50, RAD51B, RAD51C, RAD51D, XRCC211.36
12Prostate cancerEnrichmentATM, BRCA1, BRCA2, NBN, PALB2, RAD51D11.14
13Endometrial cancerEnrichmentATM, BARD1, BLM, BRCA1, BRCA2, RAD51C10.96
14Colonic benign neoplasmEnrichmentATM, MRE11, PALB26.39
15Lynch syndrome 1EnrichmentATM, PALB2, RAD51D6.24
16Diffuse midline glioma, h3 k27m-mutantEnrichmentBRCA2, BRIP15.52
17Microcephaly, growth restriction, and increased sister chromatid exchange 2EnrichmentRMI2, TOP3A5.52
18Inflammatory breast carcinomaEnrichmentBRCA1, BRCA25.52
19Bilateral breast cancerEnrichmentBRCA1, BRCA25.52
20Neuroendocrine tumor of pancreasEnrichmentBRCA2, PALB25.52
21Hereditary site-specific ovarian cancer syndromeEnrichmentRAD51C, RAD51D5.05
22Bladder cancerEnrichmentATM, BRCA1, BRCA24.76
23ChordomaEnrichmentBRCA2, PALB24.75
24Polyposis syndrome, hereditary mixed, 1EnrichmentBRCA1, BRCA24.75
25CholangiocarcinomaEnrichmentBRCA1, BRCA24.75
26Nijmegen breakage syndrome-like disorderEnrichmentMRE11, RAD504.75
27Breast-ovarian cancer, familial 2EnrichmentBRCA1, BRCA24.52
28GlioblastomaEnrichmentATM, SLX44.17
29Isolated growth hormone deficiency, type iaEnrichmentBRCA2, DNA24.08
30Tracheoesophageal fistula with or without esophageal atresiaEnrichmentBRCA2, BRIP13.97
31Myeloma, multipleEnrichmentATM, BARD1, BRCA23.90
32Isolated tracheo-esophageal fistulaEnrichmentBRCA2, BRIP13.87
33Familial colorectal cancer type xEnrichmentATM, BRCA23.79
34MedulloblastomaEnrichmentBRCA2, WRN3.57
35Seckel syndromeEnrichmentDNA2, RBBP83.57
36RhabdomyosarcomaEnrichmentBRCA1, BRCA23.45
37Diffuse large b-cell lymphomaEnrichmentBRCA2, NBN3.30
38Esophageal atresia/tracheoesophageal fistulaEnrichmentBRCA2, BRIP13.30
39HepatoblastomaEnrichmentBARD1, BRCA23.21
40Hepatocellular carcinomaEnrichmentNBN, RAD503.17
41Lung cancerEnrichmentBRCA1, PALB22.84
42Palmoplantar keratoderma, punctate type iiEnrichmentBRCA12.75
43Bloom syndromeEnrichmentBLM2.75
44Seckel syndrome 2EnrichmentRBBP82.75
45Fanconi anemia, complementation group jEnrichmentBRIP12.75
46Glioma susceptibility 3EnrichmentBRCA22.75
47Mirror movements 2EnrichmentRAD512.75
48Seckel syndrome 8EnrichmentDNA22.75
49Fanconi anemia, complementation group rEnrichmentRAD512.75
50Fanconi anemia, complementation group uEnrichmentXRCC22.75
51Premature ovarian failure 17EnrichmentXRCC22.75
52Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 6EnrichmentDNA22.75
53Spermatogenic failure 50EnrichmentXRCC22.75
54Infant-type hemispheric gliomaEnrichmentBRCA12.75
55Pancreatic cancer 2EnrichmentBRCA22.75
56Jawad syndromeEnrichmentRBBP82.75
57Ataxia-telangiectasia-like disorder 1EnrichmentMRE112.75
58Endometrial serous adenocarcinomaEnrichmentATM2.75
59Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 5EnrichmentTOP3A2.75
60Rothmund-thomson syndrome, type 4EnrichmentDNA22.75
61Basal cell carcinomaEnrichmentPALB22.75
62B-cell non-hodgkin lymphomaEnrichmentATM2.75
63Primary peritoneal carcinomaEnrichmentBRCA12.75
64Fanconi anemia, complementation group pEnrichmentSLX42.58
65Ovarian dysgenesis 9EnrichmentSPIDR2.58
66Rothmund-thomson syndrome, type 2EnrichmentDNA22.45
67Fanconi anemia, complementation group nEnrichmentPALB22.45
68Pancreatic cancer 3EnrichmentPALB22.45
69Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalitiesEnrichmentKAT52.45
70Fanconi anemia, complementation group sEnrichmentBRCA12.45
71Cardiac valvular dysplasia, x-linkedEnrichmentATM2.45
72Werner syndromeEnrichmentWRN2.45
73Pancreatic cancer 4EnrichmentBRCA12.45
74Ovarian cancer 1EnrichmentBRIP12.45
75Short stature, microcephaly, and endocrine dysfunctionEnrichmentXRCC22.45
76High grade gliomaEnrichmentATM2.45
77Fanconi anemia, complementation group d1EnrichmentBRCA22.45
78T-cell prolymphocytic leukemiaEnrichmentATM2.45
79Peritoneum cancerEnrichmentBRCA12.45
80Melanoma, cutaneous malignant 6EnrichmentXRCC32.40
81Dyskeratosis congenita, autosomal recessive 5EnrichmentRTEL12.40
82Autosomal dominant dyskeratosis congenita 4EnrichmentRTEL12.40
83Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 3EnrichmentRTEL12.40
84Primary ovarian insufficiencyEnrichmentNBN, RAD51C2.32
85Ataxia-telangiectasiaEnrichmentATM2.28
86Nijmegen breakage syndromeEnrichmentNBN2.28
87Polycythemia veraEnrichmentATM2.28
88Breast-ovarian cancer, familial 3EnrichmentRAD51C2.28
89Breast-ovarian cancer, familial 4EnrichmentRAD51D2.28
90Tumor predisposition syndrome 1EnrichmentBRCA22.28
91Fanconi anemia, complementation group oEnrichmentRAD51C2.28
92Breast-ovarian cancer, familial 5EnrichmentPALB22.28
93Koolen-de vries syndromeEnrichmentATM2.28
94AdenocarcinomaEnrichmentATM2.28
95Bap1 tumor predisposition syndromeEnrichmentBRCA22.28
96Dyskeratosis congenita, x-linkedEnrichmentRTEL12.22
97Mirror movements 1EnrichmentRAD512.15
98Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemiaEnrichmentMRE112.15
99Mantle cell lymphomaEnrichmentATM2.15
100Oculomotor apraxiaEnrichmentATM2.15
101Epilepsy, progressive myoclonic, 4, with or without renal failureEnrichmentRTEL12.10
102Combined oxidative phosphorylation deficiency 24EnrichmentRTEL12.10
103Cutis laxa, autosomal recessive, type ibEnrichmentMUS812.10
104Fanconi anemia, complementation group d2EnrichmentBRIP12.05
105Kabuki syndrome 1EnrichmentBRCA21.98
106Clear cell renal cell carcinomaEnrichmentATM1.98
107Combined oxidative phosphorylation deficiency 32EnrichmentEME21.98
108Pulmonary fibrosisEnrichmentRTEL11.92
109Hoyeraal-hreidarsson syndromeEnrichmentRTEL11.92
110Renal cell carcinoma, papillary, 1EnrichmentATM1.91
111Isolated split hand-split foot malformationEnrichmentSEM11.83
112PolydactylyEnrichmentBRCA21.80
113Leukemia, acute lymphoblastic 3EnrichmentPALB21.80
114Leukemia, chronic lymphocyticEnrichmentATM1.76
115Aplastic anemiaEnrichmentNBN1.76
116Immune deficiency diseaseEnrichmentATM1.71
117Leukemia, acute lymphoblasticEnrichmentNBN1.71
118Premature menopauseEnrichmentNBN1.64
119Periventricular nodular heterotopiaEnrichmentBRCA11.61
120CataractEnrichmentWRN1.61
121Renal cell carcinoma, nonpapillaryEnrichmentATM1.58
122Wilms tumor 1EnrichmentBRCA21.58
123GliosarcomaEnrichmentATM1.55
124Giant cell glioblastomaEnrichmentATM1.53
12546 xx gonadal dysgenesisEnrichmentSPIDR1.50
126Interstitial lung disease 2EnrichmentRTEL11.48
127LissencephalyEnrichmentNBN1.44
128Dyskeratosis congenitaEnrichmentRTEL11.43
129Cerebral palsyEnrichmentBRCA21.18
130Type 2 diabetes mellitusEnrichmentWRN1.14
131Leukemia, acute myeloidEnrichmentRTEL11.12
132Male infertility with azoospermia or oligozoospermia due to single gene mutationEnrichmentXRCC21.02
133Mitochondrial diseaseEnrichmentTOP3A0.84
134Leigh syndrome, nuclearEnrichmentEME20.77
135Leigh diseaseEnrichmentEME20.74
136MicrocephalyEnrichmentNBN0.71

Loading...
Loading...
Loading...